Login to Your Account



Other News To Note


Wednesday, November 14, 2012
• Can-Fite BioPharma Ltd., of Petach, Israel, said it designated CF603, an A3 adenosine receptor allosteric modulator licensed from Leiden University, to be developed for the treatment of sexual dysfunction. Recent studies showed that adenosine functions to relax the corpus cavernosum and promote penile erection.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription